Nizubaglustat (AZ-3102)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nizubaglustat (AZ-3102), covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC) [Phase 3]